Aclarion's nociscan ai plays key role in advanced understanding of modic changes

Modic changes (mc) are mri findings associated with endplate damage, neoinnervation, and chronic low back pain (clbp) mr spectroscopy (mrs) measurement of intradiscal propionic acid (pa) can clarify mc etiology and help stratify mc patients to potentially inform better treatment decisions for clbp patients results presented at the 50th international society for the study of the lumbar spine (issls) annual meeting 2024 broomfield, co, sept. 27, 2024 (globe newswire) -- aclarion, inc., (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, announced today that the nociscan solution was utilized to better understand modic changes (mc) in patients suffering from chronic low back pain (clbp).
ACON Ratings Summary
ACON Quant Ranking